BioCentury
ARTICLE | Company News

RXi Pharmaceuticals, TransDerm deal

April 19, 2010 7:00 AM UTC

The companies partnered to evaluate transdermal delivery of RXi's sd-rxRNA compounds using TransDerm's delivery technology to treat dermatological diseases, including pachyonychia congenita, a rare ge...